GM23730
LCL from B-Lymphocyte
Description:
ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO; OTC
ORNITHINE CARBAMOYLTRANSFERASE; OTC
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases Disorders of the Urea Cycle |
Biopsy Source
|
Peripheral vein
|
Cell Type
|
B-Lymphocyte
|
Tissue Type
|
Blood
|
Transformant
|
Epstein-Barr Virus
|
Sample Source
|
LCL from B-Lymphocyte
|
Race
|
White
|
Ethnicity
|
Not Hispanic/Latino
|
Family History
|
N
|
Relation to Proband
|
proband
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by LINE assay |
|
Gene |
OTC |
Chromosomal Location |
Xp21.1 |
Allelic Variant 1 |
; OTC DEFICIENCY |
Identified Mutation |
exon 3 dup |
Remarks |
Clinically affected; symptom onset at 13 years of age; past hyperammonemic events;OTC elevated orotate after allopurinol challenge with absence of argininosuccinic acid 20uM/mM creatinine; Hyperammonemia=211 umol/L, elevated orotate and glutamine, trace citrulline; OTC pathogenic mutation: duplication of exon 3 of the OTC gene, no mutations found in OTC gene; treatments include benzoate, citrulline arginine supplement, sodium phenylbutrate, and protein restriction; normal neurological evaluation at age 4. |
Split Ratio |
1:5 |
Temperature |
37 C |
Percent CO2 |
5% |
Percent O2 |
AMBIENT |
Medium |
Roswell Park Memorial Institute Medium 1640 with 2mM L-glutamine or equivalent |
Serum |
15% fetal bovine serum Not Inactivated |
Substrate |
None specified |
Subcultivation Method |
dilution - add fresh medium |
Supplement |
- |
|